JEREMY T TAN

Allopathic & Osteopathic Physicians|Ophthalmology|Ophthalmic Plastic and Reconstructive Surgery OKLAHOMA CITY, OK NPI 1124387626

General Payments — all program years on this page

$46,484.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 133
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $16,912.08 across 35 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Kerecis Limited $12,140.768
Amgen Inc. $4,548.8420
Bioventus LLC $100.001
Merz Pharmaceuticals, LLC $39.342
PolyNovo North America LLC $24.181
Alcon Laboratories Inc $21.481
Bausch & Lomb Americas Inc. $20.241
ABBVIE INC. $17.241

By program year

Program yearAmountRecords
2018 $183.619
2019 $211.106
2020 $2,389.847
2021 $3,855.4211
2022 $8,876.2625
2023 $14,056.2140
2024 $16,912.0835

Records — PY2024 (35)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1106198482 ABBVIE INC. $17.24 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110682367 Alcon Vision LLC $21.48 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721319 Amgen Inc. $29.98 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721321 Amgen Inc. $20.32 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721323 Amgen Inc. $18.31 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721325 Amgen Inc. $108.52 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721327 Amgen Inc. $26.77 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721329 Amgen Inc. $850.00 02/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1111721331 Amgen Inc. $25.46 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721333 Amgen Inc. $1,912.50 06/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111721335 Amgen Inc. $212.50 04/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1111721337 Amgen Inc. $26.66 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721339 Amgen Inc. $28.93 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721341 Amgen Inc. $121.45 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721343 Amgen Inc. $13.56 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721345 Amgen Inc. $19.80 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721347 Amgen Inc. $22.33 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721349 Amgen Inc. $16.47 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721351 Amgen Inc. $19.62 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721353 Amgen Inc. $13.16 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111721355 Amgen Inc. $425.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1117697592 Amgen Inc. $637.50 06/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1120094963 Kerecis Limited $159.79 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120118018 Kerecis Limited $159.13 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120118020 Kerecis Limited $1,886.50 05/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1120120492 Kerecis Limited $1,043.63 04/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1120120494 Kerecis Limited $1,250.00 02/26/2024 Honoraria Undisputed 01/23/2026 View at CMS
1120120496 Kerecis Limited $5,650.00 04/01/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 View at CMS
1120121283 Kerecis Limited $649.00 10/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1120121285 Kerecis Limited $1,342.71 10/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137450347 Bioventus LLC $100.00 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137950376 Merz Pharmaceuticals, LLC $24.33 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137950378 Merz Pharmaceuticals, LLC $15.01 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140367357 Bausch & Lomb Americas Inc. $20.24 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148186203 PolyNovo North America LLC $24.18 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.